Review



hif-1 alpha antibody (h1alpha67)  (Bio-Techne corporation)


Bioz Verified Symbol Bio-Techne corporation is a verified supplier
Bioz Manufacturer Symbol Bio-Techne corporation manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    Bio-Techne corporation hif-1 alpha antibody (h1alpha67)
    Hif 1 Alpha Antibody (H1alpha67), supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 97/100, based on 1121 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hif-1 alpha antibody (h1alpha67)/product/Bio-Techne corporation
    Average 97 stars, based on 1121 article reviews
    hif-1 alpha antibody (h1alpha67) - by Bioz Stars, 2026-05
    97/100 stars

    Images



    Similar Products

    97
    Bio-Techne corporation hif-1 alpha antibody (h1alpha67)
    Hif 1 Alpha Antibody (H1alpha67), supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hif-1 alpha antibody (h1alpha67)/product/Bio-Techne corporation
    Average 97 stars, based on 1 article reviews
    hif-1 alpha antibody (h1alpha67) - by Bioz Stars, 2026-05
    97/100 stars
      Buy from Supplier

    96
    Novus Biologicals hif1a
    Mapping transcriptional regulation of Matk in neuropeptide neurons. a Chromatin accessibility signals indicating transcriptional regulation landscapes across three groups, highlighting different gene regions of Matk with precise locus positions. b A schematic diagram illustrating binding sites of five TFs within the regulatory loci for the gene Matk . c Interaction network for Matk and its TFs. Two repressors (blue; Nfib, Arnt) were consistent with reduced Matk accessibility and expression after CFA injection, while three activators (red; <t>Hif1a,</t> Bhlhe40, Smad5) opposed the repression and promoted partial recovery with TB treatment. d A cross-group analysis correlates gene expression patterns (snRNA-seq) with chromatin enrichment profiles (snATAC-seq). TSS, transcription start site. CON, saline + vehicle; CFA, CFA +vehicle; TB, CFA + tributyrin
    Hif1a, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hif1a/product/Novus Biologicals
    Average 96 stars, based on 1 article reviews
    hif1a - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    96
    Novus Biologicals nb100
    Mapping transcriptional regulation of Matk in neuropeptide neurons. a Chromatin accessibility signals indicating transcriptional regulation landscapes across three groups, highlighting different gene regions of Matk with precise locus positions. b A schematic diagram illustrating binding sites of five TFs within the regulatory loci for the gene Matk . c Interaction network for Matk and its TFs. Two repressors (blue; Nfib, Arnt) were consistent with reduced Matk accessibility and expression after CFA injection, while three activators (red; <t>Hif1a,</t> Bhlhe40, Smad5) opposed the repression and promoted partial recovery with TB treatment. d A cross-group analysis correlates gene expression patterns (snRNA-seq) with chromatin enrichment profiles (snATAC-seq). TSS, transcription start site. CON, saline + vehicle; CFA, CFA +vehicle; TB, CFA + tributyrin
    Nb100, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nb100/product/Novus Biologicals
    Average 96 stars, based on 1 article reviews
    nb100 - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    96
    Novus Biologicals hif 1α antibody
    PAARH <t>recruits</t> <t>HIF-1α</t> to CD47 promoters and activates CD47 transcription. A CUT&RUN analysis of HIF-1α binding to CD47 promoter in SNU-398 cells with PAARH overexpression or control cultured under hypoxia. B CUT&RUN analysis of HIF-1α binding to CD47 promoter in HCCLM3 cells with PAARH knockdown or control cultured under hypoxia. C CUT&RUN analysis of HIF-1α binding to CD47 promoter in CHL-1 cells with PAARH overexpression or control cultured under hypoxia. D CUT&RUN analysis of HIF-1α binding to CD47 promoter in SW620 cells with PAARH knockdown or control cultured under hypoxia. E Luciferase activity in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. F Luciferase activity in HCCLM3 cells with PAARH knockdown or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. G Luciferase activity in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. H Luciferase activity in SW620 cells with PAARH knockdown or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. I Luciferase activity in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs and luciferase reporters containing CD47 promoter. J Luciferase activity in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs and luciferase reporters containing CD47 promoter. For E-J, results are shown as the relative ratio of firefly luciferase activity to renilla luciferase activity. K qPCR analysis of CD47 mRNA expression in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. L Flow cytometry quantification of CD47 protein expression in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. M qPCR analysis of CD47 mRNA expression in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. N Flow cytometry quantification of CD47 protein expression in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. Data are shown as mean ± SD of n = 3 biological replicates. ** p < 0.01, *** p < 0.001, **** p < 0.0001, ns, not significant, by Student’s t -test (A, C, E, G) or one-way ANOVA with Dunnett’s multiple comparisons test (B, D, F, H-N)
    Hif 1α Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hif 1α antibody/product/Novus Biologicals
    Average 96 stars, based on 1 article reviews
    hif 1α antibody - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    96
    Novus Biologicals press nb100
    PAARH <t>recruits</t> <t>HIF-1α</t> to CD47 promoters and activates CD47 transcription. A CUT&RUN analysis of HIF-1α binding to CD47 promoter in SNU-398 cells with PAARH overexpression or control cultured under hypoxia. B CUT&RUN analysis of HIF-1α binding to CD47 promoter in HCCLM3 cells with PAARH knockdown or control cultured under hypoxia. C CUT&RUN analysis of HIF-1α binding to CD47 promoter in CHL-1 cells with PAARH overexpression or control cultured under hypoxia. D CUT&RUN analysis of HIF-1α binding to CD47 promoter in SW620 cells with PAARH knockdown or control cultured under hypoxia. E Luciferase activity in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. F Luciferase activity in HCCLM3 cells with PAARH knockdown or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. G Luciferase activity in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. H Luciferase activity in SW620 cells with PAARH knockdown or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. I Luciferase activity in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs and luciferase reporters containing CD47 promoter. J Luciferase activity in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs and luciferase reporters containing CD47 promoter. For E-J, results are shown as the relative ratio of firefly luciferase activity to renilla luciferase activity. K qPCR analysis of CD47 mRNA expression in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. L Flow cytometry quantification of CD47 protein expression in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. M qPCR analysis of CD47 mRNA expression in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. N Flow cytometry quantification of CD47 protein expression in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. Data are shown as mean ± SD of n = 3 biological replicates. ** p < 0.01, *** p < 0.001, **** p < 0.0001, ns, not significant, by Student’s t -test (A, C, E, G) or one-way ANOVA with Dunnett’s multiple comparisons test (B, D, F, H-N)
    Press Nb100, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/press nb100/product/Novus Biologicals
    Average 96 stars, based on 1 article reviews
    press nb100 - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    96
    Novus Biologicals anti hif 1α
    PAARH <t>recruits</t> <t>HIF-1α</t> to CD47 promoters and activates CD47 transcription. A CUT&RUN analysis of HIF-1α binding to CD47 promoter in SNU-398 cells with PAARH overexpression or control cultured under hypoxia. B CUT&RUN analysis of HIF-1α binding to CD47 promoter in HCCLM3 cells with PAARH knockdown or control cultured under hypoxia. C CUT&RUN analysis of HIF-1α binding to CD47 promoter in CHL-1 cells with PAARH overexpression or control cultured under hypoxia. D CUT&RUN analysis of HIF-1α binding to CD47 promoter in SW620 cells with PAARH knockdown or control cultured under hypoxia. E Luciferase activity in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. F Luciferase activity in HCCLM3 cells with PAARH knockdown or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. G Luciferase activity in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. H Luciferase activity in SW620 cells with PAARH knockdown or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. I Luciferase activity in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs and luciferase reporters containing CD47 promoter. J Luciferase activity in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs and luciferase reporters containing CD47 promoter. For E-J, results are shown as the relative ratio of firefly luciferase activity to renilla luciferase activity. K qPCR analysis of CD47 mRNA expression in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. L Flow cytometry quantification of CD47 protein expression in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. M qPCR analysis of CD47 mRNA expression in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. N Flow cytometry quantification of CD47 protein expression in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. Data are shown as mean ± SD of n = 3 biological replicates. ** p < 0.01, *** p < 0.001, **** p < 0.0001, ns, not significant, by Student’s t -test (A, C, E, G) or one-way ANOVA with Dunnett’s multiple comparisons test (B, D, F, H-N)
    Anti Hif 1α, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti hif 1α/product/Novus Biologicals
    Average 96 stars, based on 1 article reviews
    anti hif 1α - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    96
    Novus Biologicals anti hif1α
    PAARH <t>recruits</t> <t>HIF-1α</t> to CD47 promoters and activates CD47 transcription. A CUT&RUN analysis of HIF-1α binding to CD47 promoter in SNU-398 cells with PAARH overexpression or control cultured under hypoxia. B CUT&RUN analysis of HIF-1α binding to CD47 promoter in HCCLM3 cells with PAARH knockdown or control cultured under hypoxia. C CUT&RUN analysis of HIF-1α binding to CD47 promoter in CHL-1 cells with PAARH overexpression or control cultured under hypoxia. D CUT&RUN analysis of HIF-1α binding to CD47 promoter in SW620 cells with PAARH knockdown or control cultured under hypoxia. E Luciferase activity in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. F Luciferase activity in HCCLM3 cells with PAARH knockdown or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. G Luciferase activity in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. H Luciferase activity in SW620 cells with PAARH knockdown or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. I Luciferase activity in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs and luciferase reporters containing CD47 promoter. J Luciferase activity in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs and luciferase reporters containing CD47 promoter. For E-J, results are shown as the relative ratio of firefly luciferase activity to renilla luciferase activity. K qPCR analysis of CD47 mRNA expression in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. L Flow cytometry quantification of CD47 protein expression in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. M qPCR analysis of CD47 mRNA expression in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. N Flow cytometry quantification of CD47 protein expression in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. Data are shown as mean ± SD of n = 3 biological replicates. ** p < 0.01, *** p < 0.001, **** p < 0.0001, ns, not significant, by Student’s t -test (A, C, E, G) or one-way ANOVA with Dunnett’s multiple comparisons test (B, D, F, H-N)
    Anti Hif1α, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti hif1α/product/Novus Biologicals
    Average 96 stars, based on 1 article reviews
    anti hif1α - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    Image Search Results


    Mapping transcriptional regulation of Matk in neuropeptide neurons. a Chromatin accessibility signals indicating transcriptional regulation landscapes across three groups, highlighting different gene regions of Matk with precise locus positions. b A schematic diagram illustrating binding sites of five TFs within the regulatory loci for the gene Matk . c Interaction network for Matk and its TFs. Two repressors (blue; Nfib, Arnt) were consistent with reduced Matk accessibility and expression after CFA injection, while three activators (red; Hif1a, Bhlhe40, Smad5) opposed the repression and promoted partial recovery with TB treatment. d A cross-group analysis correlates gene expression patterns (snRNA-seq) with chromatin enrichment profiles (snATAC-seq). TSS, transcription start site. CON, saline + vehicle; CFA, CFA +vehicle; TB, CFA + tributyrin

    Journal: International Journal of Oral Science

    Article Title: Single-cell multi-omics sequencing reveals cell-specific transcriptomic and chromatin accessibility profiles in gut microbiome metabolite butyrate-produced pain modulation

    doi: 10.1038/s41368-026-00432-9

    Figure Lengend Snippet: Mapping transcriptional regulation of Matk in neuropeptide neurons. a Chromatin accessibility signals indicating transcriptional regulation landscapes across three groups, highlighting different gene regions of Matk with precise locus positions. b A schematic diagram illustrating binding sites of five TFs within the regulatory loci for the gene Matk . c Interaction network for Matk and its TFs. Two repressors (blue; Nfib, Arnt) were consistent with reduced Matk accessibility and expression after CFA injection, while three activators (red; Hif1a, Bhlhe40, Smad5) opposed the repression and promoted partial recovery with TB treatment. d A cross-group analysis correlates gene expression patterns (snRNA-seq) with chromatin enrichment profiles (snATAC-seq). TSS, transcription start site. CON, saline + vehicle; CFA, CFA +vehicle; TB, CFA + tributyrin

    Article Snippet: For validating TF-produced chromatin accessibility regulation of target genes, we performed ChIP with antibodies against predicted TFs: Thap11 (Santa Cruz, sc-517366), Hinfp (Santa Cruz, sc-373855), Hif1a (Novus, NB100-105), or Yy1 (Santa Cruz, sc-7341), and binding regions of Nop14 , Matk , Idh3b , Ndst2 , and Tomm6 were analyzed by qPCR with the respective primers (Supplementary Table ).

    Techniques: Binding Assay, Expressing, Injection, Gene Expression, Saline

    Mapping transcriptional regulation of Tomm6 in OPCs. a Chromatin accessibility signals indicating transcriptional regulation landscapes across three groups, highlighting different gene regions of Tomm6 in OPCs with precise locus positions. b A schematic diagram illustrating binding sites of four TFs within the regulatory loci for the gene Tomm6 . c A dynamic interaction network of Tomm6 and its TFs. Two activators (red; Srebf2, Hif1a) promoted Tomm6 accessibility and expression following CFA injection, while two repressors (blue; Bhlhe41, Cebpd) were involved in normalization of Tomm6 accessibility and expression after TB treatment. TSS, transcription start site. CON, saline + vehicle; CFA, CFA +vehicle; TB, CFA + tributyrin

    Journal: International Journal of Oral Science

    Article Title: Single-cell multi-omics sequencing reveals cell-specific transcriptomic and chromatin accessibility profiles in gut microbiome metabolite butyrate-produced pain modulation

    doi: 10.1038/s41368-026-00432-9

    Figure Lengend Snippet: Mapping transcriptional regulation of Tomm6 in OPCs. a Chromatin accessibility signals indicating transcriptional regulation landscapes across three groups, highlighting different gene regions of Tomm6 in OPCs with precise locus positions. b A schematic diagram illustrating binding sites of four TFs within the regulatory loci for the gene Tomm6 . c A dynamic interaction network of Tomm6 and its TFs. Two activators (red; Srebf2, Hif1a) promoted Tomm6 accessibility and expression following CFA injection, while two repressors (blue; Bhlhe41, Cebpd) were involved in normalization of Tomm6 accessibility and expression after TB treatment. TSS, transcription start site. CON, saline + vehicle; CFA, CFA +vehicle; TB, CFA + tributyrin

    Article Snippet: For validating TF-produced chromatin accessibility regulation of target genes, we performed ChIP with antibodies against predicted TFs: Thap11 (Santa Cruz, sc-517366), Hinfp (Santa Cruz, sc-373855), Hif1a (Novus, NB100-105), or Yy1 (Santa Cruz, sc-7341), and binding regions of Nop14 , Matk , Idh3b , Ndst2 , and Tomm6 were analyzed by qPCR with the respective primers (Supplementary Table ).

    Techniques: Binding Assay, Expressing, Injection, Saline

    PAARH recruits HIF-1α to CD47 promoters and activates CD47 transcription. A CUT&RUN analysis of HIF-1α binding to CD47 promoter in SNU-398 cells with PAARH overexpression or control cultured under hypoxia. B CUT&RUN analysis of HIF-1α binding to CD47 promoter in HCCLM3 cells with PAARH knockdown or control cultured under hypoxia. C CUT&RUN analysis of HIF-1α binding to CD47 promoter in CHL-1 cells with PAARH overexpression or control cultured under hypoxia. D CUT&RUN analysis of HIF-1α binding to CD47 promoter in SW620 cells with PAARH knockdown or control cultured under hypoxia. E Luciferase activity in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. F Luciferase activity in HCCLM3 cells with PAARH knockdown or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. G Luciferase activity in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. H Luciferase activity in SW620 cells with PAARH knockdown or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. I Luciferase activity in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs and luciferase reporters containing CD47 promoter. J Luciferase activity in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs and luciferase reporters containing CD47 promoter. For E-J, results are shown as the relative ratio of firefly luciferase activity to renilla luciferase activity. K qPCR analysis of CD47 mRNA expression in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. L Flow cytometry quantification of CD47 protein expression in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. M qPCR analysis of CD47 mRNA expression in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. N Flow cytometry quantification of CD47 protein expression in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. Data are shown as mean ± SD of n = 3 biological replicates. ** p < 0.01, *** p < 0.001, **** p < 0.0001, ns, not significant, by Student’s t -test (A, C, E, G) or one-way ANOVA with Dunnett’s multiple comparisons test (B, D, F, H-N)

    Journal: Cancer Cell International

    Article Title: PAARH suppresses Kupffer cell phagocytosis to promote tumor liver metastasis by upregulating CD47

    doi: 10.1186/s12935-026-04251-0

    Figure Lengend Snippet: PAARH recruits HIF-1α to CD47 promoters and activates CD47 transcription. A CUT&RUN analysis of HIF-1α binding to CD47 promoter in SNU-398 cells with PAARH overexpression or control cultured under hypoxia. B CUT&RUN analysis of HIF-1α binding to CD47 promoter in HCCLM3 cells with PAARH knockdown or control cultured under hypoxia. C CUT&RUN analysis of HIF-1α binding to CD47 promoter in CHL-1 cells with PAARH overexpression or control cultured under hypoxia. D CUT&RUN analysis of HIF-1α binding to CD47 promoter in SW620 cells with PAARH knockdown or control cultured under hypoxia. E Luciferase activity in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. F Luciferase activity in HCCLM3 cells with PAARH knockdown or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. G Luciferase activity in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. H Luciferase activity in SW620 cells with PAARH knockdown or control cultured under hypoxia after transfection of luciferase reporters containing CD47 promoter. I Luciferase activity in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs and luciferase reporters containing CD47 promoter. J Luciferase activity in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs and luciferase reporters containing CD47 promoter. For E-J, results are shown as the relative ratio of firefly luciferase activity to renilla luciferase activity. K qPCR analysis of CD47 mRNA expression in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. L Flow cytometry quantification of CD47 protein expression in SNU-398 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. M qPCR analysis of CD47 mRNA expression in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. N Flow cytometry quantification of CD47 protein expression in CHL-1 cells with PAARH overexpression or control cultured under hypoxia after transfection of HIF-1α specific siRNAs. Data are shown as mean ± SD of n = 3 biological replicates. ** p < 0.01, *** p < 0.001, **** p < 0.0001, ns, not significant, by Student’s t -test (A, C, E, G) or one-way ANOVA with Dunnett’s multiple comparisons test (B, D, F, H-N)

    Article Snippet: The binding of HIF-1α to CD47 promoter were evaluated by CUT&RUN assays using the CUT&RUN Assay Kit (Cell Signaling Technology, Danvers, MA, USA) and HIF-1α antibody (Cat. No. NB100-105; Novus, Saint Louis, MO, USA).

    Techniques: Binding Assay, Over Expression, Control, Cell Culture, Knockdown, Luciferase, Activity Assay, Transfection, Expressing, Flow Cytometry